Strides Pharma Science Ltd

Strides Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Strides Pharma Science Ltd

₹ 952 -0.12%
22 Jul 3:28 p.m.
strides.com BSE: 532531 NSE: STAR
About

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.[1] The company's pharmaceutical products are sold in over 100 countries.[2]
The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.[3]

Key Points

About[1]
Incorporated in 1990, Strides operates in the pharmaceutical industry, manufacturing generic formulations in various dosage forms.

Website BSE NSE
  • Market Cap ₹ 8,746 Cr.
  • Current Price ₹ 952
  • High / Low ₹ 994 / 412
  • Stock P/E 3,651
  • Book Value ₹ 231
  • Dividend Yield 0.16 %
  • ROCE 7.91 %
  • ROE 0.11 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 4.11 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding is low: 25.9%
  • Company has a low return on equity of -6.03% over last 3 years.
  • Promoters have pledged 64.6% of their holding.
  • Promoter holding has decreased over last 3 years: -3.76%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
908 688 721 794 866 940 897 865 986 930 999 1,038 1,084
772 758 759 817 868 936 844 892 871 796 889 896 903
Operating Profit 137 -70 -37 -23 -1 4 53 -27 115 134 111 142 181
OPM % 15% -10% -5% -3% -0% 0% 6% -3% 12% 14% 11% 14% 17%
12 -78 -38 -5 9 -52 57 68 20 3 -129 53 -22
Interest 42 41 44 42 49 55 68 58 81 76 79 79 80
Depreciation 52 55 57 61 61 60 62 60 61 60 60 51 50
Profit before tax 55 -244 -175 -131 -103 -163 -20 -78 -7 0 -157 64 30
Tax % 21% -15% -4% -3% -128% -17% -197% 5% 106% 3,025% -5% 16% 65%
44 -209 -168 -127 29 -135 19 -82 -14 -9 -149 54 10
EPS in Rs 5.14 -22.87 -18.11 -13.55 3.25 -15.13 2.53 -8.86 -1.06 -0.79 -14.54 5.41 1.98
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
962 1,341 1,196 2,861 2,755 2,845 2,178 2,752 3,316 3,070 3,688 4,051
861 1,567 967 2,486 2,228 2,448 1,982 2,351 2,779 3,201 3,544 3,484
Operating Profit 101 -226 229 374 527 398 197 401 537 -131 145 568
OPM % 10% -17% 19% 13% 19% 14% 9% 15% 16% -4% 4% 14%
959 3,281 874 63 291 643 303 -30 109 -112 92 -95
Interest 79 109 47 168 183 196 79 156 150 177 261 314
Depreciation 31 56 64 131 126 154 117 174 206 233 243 221
Profit before tax 949 2,890 992 137 509 690 303 42 289 -653 -268 -63
Tax % 11% 39% 15% 31% 12% 1% -9% 27% 11% -27% -21% 50%
847 1,767 844 95 446 684 330 31 258 -474 -212 -94
EPS in Rs 143.92 296.43 141.78 12.15 44.71 74.25 36.25 4.06 29.93 -51.25 -22.44 -7.68
Dividend Payout % 1% 170% 76% 41% 10% 3% 8% 345% 8% 0% -7% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 13%
3 Years: 7%
TTM: 10%
Compounded Profit Growth
10 Years: -48%
5 Years: -62%
3 Years: -78%
TTM: 101%
Stock Price CAGR
10 Years: 4%
5 Years: 23%
3 Years: 7%
1 Year: 116%
Return on Equity
10 Years: 10%
5 Years: -1%
3 Years: -6%
Last Year: 0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 59 60 60 89 89 90 90 90 90 90 90 92
Reserves 1,967 947 1,085 2,569 2,659 2,374 2,559 2,438 2,687 2,269 2,105 2,034
1,594 547 892 3,542 3,700 2,520 3,221 2,235 2,348 3,025 3,030 2,517
1,175 543 438 1,211 1,598 1,601 1,937 1,369 1,844 1,556 1,369 1,197
Total Liabilities 4,796 2,096 2,475 7,410 8,046 6,585 7,807 6,131 6,969 6,940 6,594 5,840
3,017 555 701 2,679 2,980 2,977 3,648 2,099 2,219 2,347 2,311 1,947
CWIP 241 99 171 815 780 620 453 413 447 291 151 80
Investments 0 443 630 1,341 1,525 588 702 549 697 540 490 303
1,538 999 972 2,576 2,762 2,400 3,005 3,070 3,605 3,762 3,642 3,510
Total Assets 4,796 2,096 2,475 7,410 8,046 6,585 7,807 6,131 6,969 6,940 6,594 5,840

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
139 -272 83 73 288 187 60 205 481 -258 44 701
771 4,044 50 -2,205 -1,222 570 -145 1,321 -522 -119 302 -150
-990 -3,319 -421 2,944 338 -1,016 194 -1,709 -16 421 -214 -693
Net Cash Flow -80 454 -288 812 -596 -259 110 -184 -56 45 133 -143

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 183 99 119 132 132 113 165 124 122 144 129 103
Inventory Days 328 90 135 149 209 146 294 254 329 285 257 251
Days Payable 344 137 153 188 221 188 299 259 311 260 220 189
Cash Conversion Cycle 168 52 102 92 120 71 160 119 140 168 165 164
Working Capital Days 18 53 -29 96 63 117 155 95 116 210 156 151
ROCE % 27% 113% 57% 8% 11% 16% 6% 5% 8% -5% -0% 8%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
29.60% 29.60% 30.60% 30.37% 31.08% 30.90% 28.28% 28.08% 27.79% 27.39% 25.88% 25.86%
24.96% 19.85% 19.66% 21.21% 21.43% 18.98% 18.85% 16.72% 17.25% 19.45% 24.57% 26.71%
20.44% 21.08% 18.82% 16.63% 15.07% 18.44% 17.88% 19.60% 19.50% 19.02% 17.66% 18.17%
0.00% 0.00% 0.00% 0.00% 0.40% 0.40% 0.40% 0.40% 0.40% 0.39% 0.39% 0.39%
25.00% 29.47% 30.92% 31.79% 32.05% 31.29% 34.60% 35.22% 35.06% 33.75% 31.52% 28.87%
No. of Shareholders 1,06,9271,25,5531,33,1901,34,7181,30,6821,23,9641,20,9161,12,7751,01,63891,18284,69591,917

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls